Skip to content
EntityQ904673· pop 11· linked from 1,129 articles

Also known as pramindole, 3-(6,7,8,9,10,11-hexahydro- 5H-cycloocta[b]indol-5-yl)-N,N-dimethylpropan-1-amine, Prondol, Galatur, Tertran

Iprindole, sold under the brand names Prondol, Galatur, and Tertran, is an atypical tricyclic antidepressant (TCA) that has been used in the United Kingdom and Ireland for the treatment of depression but appears to no longer be marketed. It was developed by Wyeth and was marketed in 1967. The drug has been described by some as the first "second-generation" antidepressant to be introduced. However, it was very little-used compared to other TCAs, with the number of prescriptions dispensed only in the thousands.

Key facts

Drug.Watchedfields
changed
Drug.verifiedrevid
439569389
Drug.IUPAC_name
3-(6,7,8,9,10,11-hexahydro-5H-cycloocta[b]indol-5-yl)-N,N-dimethylpropan-1-amine
Drug.image
Iprindole.svg
Drug.image_class
skin-invert-image
Drug.width
200px
Drug.image2
Iprindole molecule ball.png
Drug.image_class2
bg-transparent
Drug.width2
200px
Drug.tradename
Prondol, Galatur, Tertran
Drug.legal_status
Rx-only
Drug.routes_of_administration
Oral
Drug.metabolism
Hepatic
Drug.elimination_half life
52.5 hours
Drug.excretion
Urine, Feces
Drug.CAS_number
5560-72-5
Drug.CAS_supplemental
20432-64-8 (hydrochloride)
Drug.ATC_prefix
N06

via Wikipedia infobox

Wikidata facts

Mass
284.225
Show 4 more facts
chemical formula
C₁₉H₂₈N₂
defined daily dose
90
canonical SMILES
CN(C)CCCN1C2=C(CCCCCC2)C3=CC=CC=C31
Commons category
Iprindole
Sources (3)

via Wikidata · CC0

~7 min read

Article

16 sections
Contents
  • Medical uses
  • Contraindications
  • Side effects
  • Overdose
  • Interactions
  • Pharmacology
  • Pharmacodynamics
  • Pharmacokinetics
  • Chemistry
  • History
  • Society and culture
  • Generic names
  • Brand names
  • Availability
  • References
  • Further reading

Iprindole, sold under the brand names Prondol, Galatur, and Tertran, is an atypical tricyclic antidepressant (TCA) that has been used in the United Kingdom and Ireland for the treatment of depression but appears to no longer be marketed. It was developed by Wyeth and was marketed in 1967. The drug has been described by some as the first "second-generation" antidepressant to be introduced. However, it was very little-used compared to other TCAs, with the number of prescriptions dispensed only in the thousands.

==Medical uses== Iprindole was used in the treatment of major depressive disorder in dosages similar to those of other TCAs.

Available in 10 languages

via Wikidata sitelinks · CC0

Connections

Categories